{"id":56161,"date":"2024-02-07T05:55:19","date_gmt":"2024-02-07T05:55:19","guid":{"rendered":"https:\/\/medsname.com\/citapad\/"},"modified":"2026-04-30T10:24:40","modified_gmt":"2026-04-30T10:24:40","slug":"citapad","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/citapad\/","title":{"rendered":"Citapad"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8d6;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">\u26a1 R\u0103spuns rapid<\/h3>\n<p style=\"margin-bottom:0;\">Citapad (Citalopram 10 \/ 20 \/ 40 mg) este un inhibitor selectiv de recaptare a serotoninei utilizat \u00een depresie, anxietate \u0219i tulbur\u0103ri conexe. Efectul antidepresiv apare progresiv \u2014 este necesar un tratament de 4\u20136 s\u0103pt\u0103m\u00e2ni pentru evaluarea corect\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Citapad de la MedsBase este furnizat direct de la un produc\u0103tor certificat WHO-GMP, \u00een ambalaje discrete \u0219i neutre. Fiecare comand\u0103 este acoperit\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a> \u2014 perioad\u0103 de livrare de 20 de zile lucr\u0103toare sau retrimitem f\u0103r\u0103 costuri suplimentare \u2014 \u0219i se calific\u0103 pentru <a href=\"https:\/\/medsbase.com\/ro\/loyalty-points\/\">programul nostru de loialitate pentru clien\u021bi<\/a>. Livr\u0103rile sunt disponibile \u00een majoritatea destina\u021biilor la nivel mondial.<\/p>\n<h2>Cum func\u021bioneaz\u0103 Citapad<\/h2>\n<p><strong>Citapad<\/strong> este un comprimat SSRI care con\u021bine Citalopram, furnizat de Cipla. Doze disponibile: <strong>10 \/ 20 \/ 40 mg<\/strong>. Se administr\u0103 cu sau f\u0103r\u0103 alimente, \u00een acela\u0219i moment al zilei pentru a men\u021bine niveluri plasmatice constante.<\/p>\n<p>SSRI-urile blocheaz\u0103 recaptarea serotonin\u0103i (5-HT) la nivelul transportorului serotoninergic presinaptic (SERT), cresc\u00e2nd disponibilitatea serotonin\u0103i sinaptice. Efectul terapeutic \u00eent\u00e2rzie blocarea transportorului cu 2\u20136 s\u0103pt\u0103m\u00e2ni \u2014 \u00eent\u00e2rzierea reflect\u0103 adapt\u0103ri descendente \u00een sensibilitatea autoreceptorilor 5-HT, expresia BDNF \u0219i neurogeneza hippocampal\u0103, nu efecte directe asupra receptorilor. Pacien\u021bii care nu simt \u201cniciun efect\u201d la 2 s\u0103pt\u0103m\u00e2ni nu ar trebui s\u0103 \u00eentrerup\u0103 tratamentul; evalua\u021bi r\u0103spunsul dup\u0103 4\u20136 s\u0103pt\u0103m\u00e2ni de la administrarea unei doze adecvate.<\/p>\n<p>Citalopramul este un <strong>SSRI racemic<\/strong> \u2014 enantiomerul R adaug\u0103 pu\u021bin\u0103 activitate antidepresiv\u0103, dar contribuie cel mai mult la semnalul QT. Escitalopramul (Lexaheal, enantiomerul S) atinge acela\u0219i efect terapeutic la jum\u0103tate din doz\u0103, cu un risc QT semnificativ mai mic.<\/p>\n<h2>Indica\u021bii \u0219i dozaj<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indica\u021bie<\/th>\n<th>Doza ini\u021bial\u0103<\/th>\n<th>\u021aint\u0103<\/th>\n<th>Maxim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Depresie major\u0103<\/td>\n<td>20 mg OD<\/td>\n<td>20\u201340 mg OD<\/td>\n<td>40 mg (20 mg dac\u0103 &gt;60 ani)<\/td>\n<\/tr>\n<tr>\n<td>Anxietate generalizat\u0103 \/ panic\u0103<\/td>\n<td>10 mg OD \u00d7 1 s\u0103pt.<\/td>\n<td>20 mg OD<\/td>\n<td>40 mg<\/td>\n<\/tr>\n<tr>\n<td>Pacien\u021bi \u00een v\u00e2rst\u0103 \/ Metabolizatori slabi CYP2C19 \/ Inhibitori CYP2C19<\/td>\n<td>10 mg OD<\/td>\n<td>10\u201320 mg o dat\u0103 pe zi<\/td>\n<td>20 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Considera\u021bii importante de siguran\u021b\u0103<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Limit\u0103 FDA doz\u0103 maxim\u0103 \u2014 prelungire interval QT<\/strong><\/p>\n<p style=\"margin-bottom:0;\">\u00cen 2011, FDA a limitat doza zilnic\u0103 maxim\u0103 de citalopram la <strong>40 mg\/zi<\/strong> \u00een popula\u021bia general\u0103 \u0219i <strong>20 mg\/zi<\/strong> la adul\u021bii peste 60 de ani, la metabolizatorii slabi CYP2C19 \u0219i la pacien\u021bii care iau inhibitori CYP2C19 (omeprazol, esomeprazol, fluvoxamin\u0103, cimetidin\u0103). Dozele peste 40 mg provoac\u0103 prelungirea intervalului QT dependent\u0103 de doz\u0103. <strong>Dac\u0103 ave\u021bi sindrom QT lung congenital, hipokaliemie, hipomagnezemie, infarct miocardic recent sau insuficien\u021b\u0103 cardiac\u0103 necompensat\u0103, citalopramul nu este SSRI-ul potrivit<\/strong> \u2014 sertralina este alternativa farmacologic\u0103 cea mai apropiat\u0103 f\u0103r\u0103 semnal QT.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Avertisment cutie neagr\u0103 privind riscul de suicid (sub 25 de ani)<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Toate SSRI-urile poart\u0103 un avertisment FDA \u00een cadru negru pentru cre\u0219terea g\u00e2ndurilor suicidare la pacien\u021bii sub 25 de ani, \u00een special \u00een primele 4 s\u0103pt\u0103m\u00e2ni \u0219i la modific\u0103rile de doz\u0103. Acest lucru nu <em>prime\u0219te,<\/em> \u00eenseamn\u0103 c\u0103 SSRI-urile sunt d\u0103un\u0103toare net la tineri \u2014 meta-analizele arat\u0103 beneficii nete \u2014 dar \u00eenseamn\u0103 monitorizare clinic\u0103 atent\u0103 \u00een timpul ini\u021bierii \u0219i titr\u0103rii la adolescen\u021bi \u0219i tineri adul\u021bi.<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Sindrom serotoninergic<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Combinarea Citapad cu alte agen\u021bi serotoninergici poate provoca sindrom serotoninergic (tremur, hiperreflexie, clonus, hipertermie, agita\u021bie). Evita\u021bi administrarea concomitent\u0103 cu: IMAO (perioad\u0103 de eliminare de 14 zile \u00een ambele sensuri; fluoxetina necesit\u0103 5 s\u0103pt\u0103m\u00e2ni), tramadol, petidin\u0103, dextrometorfan, linezolid, albastru de metilen, sun\u0103toarea, MDMA. Triptan + SSRI este \u00een general tolerat pentru migren\u0103 \u2014 riscul absolut este sc\u0103zut.<\/p>\n<\/div>\n<h2>Efecte secundare frecvente<\/h2>\n<ul>\n<li><strong>Primele 1\u20132 s\u0103pt\u0103m\u00e2ni:<\/strong> gre\u021buri, cefalee, agita\u021bie\/criz\u0103 de anxietate, insomnie sau somnolen\u021b\u0103, scaune moi \u2014 de obicei se autolimiteaz\u0103.<\/li>\n<li><strong>Persistent:<\/strong> disfunc\u021bie sexual\u0103 (libido sc\u0103zut, orgasm \u00eent\u00e2rziat\/anorgasmie, dificultate de erec\u021bie \u2014 afecteaz\u0103 p\u00e2n\u0103 la 50% dintre b\u0103rba\u021bi \u0219i femei care iau SSRI; motivul cel mai frecvent pentru \u00eentreruperea tratamentului), modific\u0103ri ale greut\u0103\u021bii (cre\u0219tere modest\u0103 pe 6\u201312 luni), bruxism, gur\u0103 uscat\u0103, transpira\u021bii excesive.<\/li>\n<li><strong>Rar dar important:<\/strong> hiponatremie (SIADH, \u00een special la persoanele \u00een v\u00e2rst\u0103 \u2014 verifica\u021bi Na\u207a la 2 \u0219i 4 s\u0103pt\u0103m\u00e2ni dac\u0103 exist\u0103 risc), s\u00e2nger\u0103ri (risc adi\u021bional cu AINS\/anticoagulante \u2014 lua\u021bi \u00een considerare acoperire cu PPI), pierdere de densitate osoas\u0103 la utilizare pe termen lung.<\/li>\n<\/ul>\n<h2>Interac\u021biuni medicamentoase<\/h2>\n<p>Pe l\u00e2ng\u0103 interac\u021biunile specifice men\u021bionate mai sus:<\/p>\n<ul>\n<li><strong>AINS \/ aspirin\u0103 \/ anticoagulante<\/strong> \u2014 risc crescut de s\u00e2nger\u0103ri; utiliza\u021bi un PPI pentru persoanele \u00een v\u00e2rst\u0103 care iau AINS cronic + SSRI.<\/li>\n<li><strong>Alte medicamente care prelungesc intervalul QT<\/strong> (amiodaron\u0103, sotalol, metadon\u0103, ondansetron, haloperidol, ziprasidon\u0103) \u2014 risc adi\u021bional.<\/li>\n<li><strong>Litiu<\/strong> \u2014 semnal serotoninergic crescut; monitoriza\u021bi pentru sindrom serotoninergic \u0219i toxicitate de litiu.<\/li>\n<li><strong>Depresante ale SNC<\/strong> (alcool, benzodiazepine, opioide) \u2014 efect sedativ adi\u021bional.<\/li>\n<\/ul>\n<h2>Sarcina, al\u0103ptare, pediatric<\/h2>\n<p>Majoritatea SSRI sunt <strong>categoria C<\/strong> acceptabile \u00een timpul sarcinii cu un profil risc-beneficiu acceptabil atunci c\u00e2nd depresia \u00een sine prezint\u0103 un risc real. Paroxetina este excep\u021bia \u2014 expunerea \u00een primul trimestru a fost asociat\u0103 cu cre\u0219teri absolute mici ale malforma\u021biilor cardiace. Sertralina este \u00een general considerat\u0103 SSRI-ul de alegere \u00een sarcin\u0103 \u0219i al\u0103ptare. Expunerea la SSRI \u00een ultimul trimestru poate produce un sindrom de adaptare neonatal\u0103 tranzitorie (agita\u021bie, dificult\u0103\u021bi de hr\u0103nire) care se rezolv\u0103 de obicei \u00een 1\u20132 s\u0103pt\u0103m\u00e2ni. Discuta\u021bi orice modificare \u00een timpul sarcinii cu medicul prescriptor \u2014 \u00eentreruperea brusc\u0103 \u00een timpul sarcinii poate avea propriul risc (reapari\u021bia simptomelor).<\/p>\n<h2>Depozitare<\/h2>\n<p>Depozita\u021bi la 15\u201330 \u00b0C \u00eentr-un loc uscat, departe de lumina direct\u0103 a soarelui \u0219i \u00een afara reach-ului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>C\u00e2t dureaz\u0103 p\u00e2n\u0103 \u00eencepe s\u0103 actioneze Citapad?<\/h3>\n<p>Unii pacien\u021bi observ\u0103 efecte timpurii asupra somnului \u0219i anxiet\u0103\u021bii \u00een 1\u20132 s\u0103pt\u0103m\u00e2ni, dar efectul antidepresiv sau anti-anxietate complet necesit\u0103 de obicei 4\u20136 s\u0103pt\u0103m\u00e2ni la o doz\u0103 adecvat\u0103. Nu concluziona\u021bi c\u0103 Citapad nu func\u021bioneaz\u0103 p\u00e2n\u0103 nu a\u021bi luat medicamentul timp de cel pu\u021bin 4 s\u0103pt\u0103m\u00e2ni la o doz\u0103 terapeutic\u0103.<\/p>\n<h3>Pot consuma alcool \u00een timp ce iau Citapad?<\/h3>\n<p>Alcoolul nu interac\u021bioneaz\u0103 chimic cu SSRI-urile \u00eentr-un mod periculos la consum moderat, dar agraveaz\u0103 depresia de baz\u0103 \u0219i amplific\u0103 efectul sedativ al SSRI-urilor. Mul\u021bi psihiatri recomand\u0103 minimizarea consumului de alcool \u00een primele 4\u20138 s\u0103pt\u0103m\u00e2ni, \u00een timp ce efectul medicamentului se stabilizeaz\u0103.<\/p>\n<h3>Citapad \u00eemi va schimba personalitatea?<\/h3>\n<p>Nu. Pacien\u021bii trata\u021bi corespunz\u0103tor descriu c\u0103 se simt mai mult ca ei \u00een\u0219i\u0219i, nu mai pu\u021bin. Dac\u0103 dup\u0103 c\u00e2teva s\u0103pt\u0103m\u00e2ni sim\u021bi\u021bi c\u0103 emo\u021biile sunt amortite, c\u0103 sunte\u021bi dezconectat sexual sau deta\u0219at, discuta\u021bi acest lucru cu medicul prescriptor \u2014 poate fi legat de doz\u0103 sau de medicamentul specific \u0219i de cele mai multe ori poate fi gestionat.<\/p>\n<h3>Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi medicamentul imediat ce v\u0103 aminti\u021bi \u00een aceea\u0219i zi. Dac\u0103 este aproape timpul pentru urm\u0103toarea doz\u0103, omite\u021bi cea ratat\u0103. Nu lua\u021bi niciodat\u0103 o dobl\u0103 doz\u0103. La SSRI-urile cu timp de \u00eenjum\u0103t\u0103\u021bire scurt (paroxetin\u0103, fluvoxamin\u0103), o doz\u0103 ratat\u0103 poate provoca simptome de sevraj u\u0219oare \u2014 lua\u021bi-o imediat ce v\u0103 aminti\u021bi.<\/p>\n<h3>Pot s\u0103 opresc Citapad c\u00e2nd m\u0103 simt mai bine?<\/h3>\n<p>Nu \u2014 \u00eentreruperea dup\u0103 4\u20136 s\u0103pt\u0103m\u00e2ni de ameliorare este cea mai frecvent\u0103 cauz\u0103 de recidiv\u0103. Majoritatea ghidurilor recomand\u0103 continuarea unui antidepresiv eficient pentru cel pu\u021bin 6\u201312 luni dup\u0103 remisiunea complet\u0103 a primului episod, mai mult pentru depresia sau anxietatea recurent\u0103. Reduce\u021bi treptat doza \u00een loc s\u0103 opri\u021bi brusc.<\/p>\n<h3>Citapad provoac\u0103 cre\u0219tere \u00een greutate?<\/h3>\n<p>Majoritatea SSRI-urilor provoac\u0103 o cre\u0219tere modest\u0103 \u00een greutate pe parcursul a 6\u201312 luni (adesea 2\u20134 kg). Fluoxetina este cel mai neutr\u0103 din punct de vedere al greut\u0103\u021bii sau chiar u\u0219or reduc\u0103toare de greutate dintre SSRI-uri \u00een unele studii. Dac\u0103 cre\u0219terea \u00een greutate este o preocupare major\u0103, merit\u0103 discutat\u0103 cu medicul prescriptor atunci c\u00e2nd alege\u021bi sau schimba\u021bi medicamentul.<\/p>\n<h3>Citapad poate fi combinat cu terapie?<\/h3>\n<p>Combinarea unui SSRI cu psihoterapie structurat\u0103 (TCC pentru depresie \u0219i anxietate; ERP pentru TOC) dep\u0103\u0219e\u0219te \u00een mod constant efectul fiec\u0103ruia separat \u00een cazul bolilor moderate p\u00e2n\u0103 la severe. Medicamentul abordeaz\u0103 deregl\u0103rile biologice; terapia abordeaz\u0103 modelele cognitive \u0219i comportamentale.<\/p>\n<h3>Cum reduc progresiv doza de Citapad?<\/h3>\n<p>Pentru majoritatea SSRI-lor, reducerea treptat\u0103 se face \u00een 4\u20138 s\u0103pt\u0103m\u00e2ni prin \u00eenjum\u0103t\u0103\u021birea dozei la fiecare 2 s\u0103pt\u0103m\u00e2ni. Paroxetina \u0219i fluvoxamina necesit\u0103 reducere mai lent\u0103 (adesea 8\u201312 s\u0103pt\u0103m\u00e2ni) datorit\u0103 timpului scurt de \u00eenjum\u0103t\u0103\u021bire. Unii pacien\u021bi necesit\u0103 reducere hiperbolic\u0103 (sc\u0103deri de 10% la fiecare 2\u20134 s\u0103pt\u0103m\u00e2ni) \u00een fazele finale. Medicul prescriptor ar trebui s\u0103 planifice acest proces \u00eempreun\u0103 cu dumneavoastr\u0103.<\/p>\n<h3>Este Citapad adictiv?<\/h3>\n<p>SSRI nu sunt adictive \u00een sensul tulbur\u0103rii de consum de substan\u021be \u2014 nu produc efect euforic, nu exist\u0103 utilizare compulsiv\u0103 \u0219i nici toleran\u021b\u0103 cresc\u00e2nd\u0103. Acestea creeaz\u0103 \u00eens\u0103 <strong>dependen\u021b\u0103 fizic\u0103<\/strong>: \u00eentreruperea brusc\u0103 provoac\u0103 simptome de sevraj (sindrom de suspendare). Aceast\u0103 dependen\u021b\u0103 nu este dependen\u021b\u0103; este o adaptare farmacologic\u0103 previzibil\u0103 care se rezolv\u0103 prin reducerea progresiv\u0103 adecvat\u0103.<\/p>\n<h3>Ce fac dac\u0103 vreau s\u0103 schimb antidepresivele?<\/h3>\n<p>Majoritatea schimb\u0103rilor \u00eentre SSRI se fac prin trecere direct\u0103 sau perioad\u0103 scurt\u0103 de eliminare. Trecerea de la sau c\u0103tre un MAOI necesit\u0103 o perioad\u0103 strict\u0103 de eliminare (14 zile; 5 s\u0103pt\u0103m\u00e2ni dac\u0103 se \u00eentrerupe fluoxetina din cauza timpului lung de \u00eenjum\u0103t\u0103\u021bire) pentru a evita sindromul serotoninergic. Schimbarea este o decizie luat\u0103 sub supraveghere medical\u0103.<\/p>\n<h2>Alte Medicamente pentru S\u0103n\u0103tatea Mintal\u0103<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lexaheal\/\">Lexaheal (Escitalopram 5\/10\/20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/flunil\/\">Flunil (Fluoxetin\u0103 20\/40 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/pexep\/\">Pexep (Paroxetin\u0103 12.5\u201337.5 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/duvanta\/\">Duvanta (Duloxetine SNRI)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/mirtaz\/\">Mirtaz (Mirtazapine NaSSA)<\/a><\/li>\n<\/ul>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;font-size:0.9em;\">\n<strong>Not\u0103 medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop educa\u021bional \u0219i nu \u00eenlocuie\u0219te sfatul medical personalizat. Farmacoterapia pentru s\u0103n\u0103tatea mintal\u0103 ar trebui ini\u021biat\u0103, monitorizat\u0103 \u0219i ajustat\u0103 de c\u0103tre un clinician calificat. Dac\u0103 tu sau cineva cunoscut se afl\u0103 \u00eentr-o criz\u0103 suicidal\u0103, contacteaz\u0103 imediat serviciile de urgen\u021b\u0103 locale sau sun\u0103 la linia de preven\u021bie a suicidului din \u021bara ta (SUA\/Canada: 988; UK: Samaritans 116 123; list\u0103 interna\u021bional\u0103: <a href=\"https:\/\/findahelpline.com\/\" rel=\"nofollow noopener\" target=\"_blank\">findahelpline.com<\/a>).\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Citapad (Citalopram 10\/20\/40 mg) \u2014 SSRI racemic pentru depresia major\u0103 \u0219i anxietate. Sensibil la CYP2C19 \u2014 doza maxim\u0103 de 40 mg (20 mg la pacien\u021bii peste 60 de ani).<\/p>","protected":false},"featured_media":56162,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3906],"product_tag":[4066,4067],"class_list":{"0":"post-56161","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_tag-citalopram","10":"product_tag-citapad","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/56161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=56161"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/56162"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=56161"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=56161"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=56161"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=56161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}